TY - JOUR
T1 - Synthesis of novel 68Ga-labeled amino acid derivatives for positron emission tomography of cancer cells
AU - Shetty, Dinesh
AU - Jeong, Jae Min
AU - Ju, Chang Hwan
AU - Lee, Yun Sang
AU - Jeong, Seo Young
AU - Choi, Jae Yeon
AU - Yang, Bo Yeun
AU - Lee, Dong Soo
AU - Chung, June Key
AU - Lee, Myung Chul
N1 - Funding Information:
We appreciate NRF of Korea grant R0A-2008-000-20116-0 and 2009-0082087 funded by Ministry of Education, Science and Technology.
PY - 2010/11
Y1 - 2010/11
N2 - Objectives: We developed amino acid derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid (DO2A) and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid (DO3A) that can be labeled with 68Ga, and we investigated their basic biological properties. Materials and methods: Alanine derivatives of DO2A and DO3A were synthesized by regiospecific nucleophilic attack of DO2tBu and DO3tBu on the β-position of Boc-l-serine-β-lactone, followed by acid hydrolysis. Also, homoalanine derivatives were synthesized by reacting with the protected bromo derivative of homoalanine, which was synthesized from N-Cbz-l-homoserine lactone. Further catalytic reduction and acid cleavage of protected groups resulted in the required products. All derivatives were labeled with 68Ga. Cell uptake assays were carried out in Hep3B (human hepatoma) and U87MG (human glioma) cell lines at 37°C. Positron emission tomography (PET) imaging studies were performed using balb/c mice xenografted with CT-26 (mouse colon cancer). Results: All compounds were labeled with >97% efficiency. According to in vitro studies, the labeled amino acid derivatives showed significantly greater uptakes than the control (68Ga 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) in cancer cells. Small animal PET images for labeled compounds showed high tumor uptake, as well as kidney and bladder uptakes, at 30 min postinjection. 68Ga-DO3A-homoalanine showed the highest standardized uptake value ratio (3.9±0.3), followed by 68Ga-DO2A-alanine (3.1±0.2), 68Ga-DO3A-alanine (2.8±0.2) and 68Ga-DO2A-homoalanine (2.3±0.2). Conclusion: These derivatives were found to have high labeling efficiencies, high stabilities, high tumor cell uptakes, high tumor/nontumor xenograft uptakes and low nonspecific uptake in normal organs, except for the kidneys. However, the uptake mechanism of these derivatives remains unclear, and uptake via specific amino acid transporters needs to be demonstrated.
AB - Objectives: We developed amino acid derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid (DO2A) and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid (DO3A) that can be labeled with 68Ga, and we investigated their basic biological properties. Materials and methods: Alanine derivatives of DO2A and DO3A were synthesized by regiospecific nucleophilic attack of DO2tBu and DO3tBu on the β-position of Boc-l-serine-β-lactone, followed by acid hydrolysis. Also, homoalanine derivatives were synthesized by reacting with the protected bromo derivative of homoalanine, which was synthesized from N-Cbz-l-homoserine lactone. Further catalytic reduction and acid cleavage of protected groups resulted in the required products. All derivatives were labeled with 68Ga. Cell uptake assays were carried out in Hep3B (human hepatoma) and U87MG (human glioma) cell lines at 37°C. Positron emission tomography (PET) imaging studies were performed using balb/c mice xenografted with CT-26 (mouse colon cancer). Results: All compounds were labeled with >97% efficiency. According to in vitro studies, the labeled amino acid derivatives showed significantly greater uptakes than the control (68Ga 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) in cancer cells. Small animal PET images for labeled compounds showed high tumor uptake, as well as kidney and bladder uptakes, at 30 min postinjection. 68Ga-DO3A-homoalanine showed the highest standardized uptake value ratio (3.9±0.3), followed by 68Ga-DO2A-alanine (3.1±0.2), 68Ga-DO3A-alanine (2.8±0.2) and 68Ga-DO2A-homoalanine (2.3±0.2). Conclusion: These derivatives were found to have high labeling efficiencies, high stabilities, high tumor cell uptakes, high tumor/nontumor xenograft uptakes and low nonspecific uptake in normal organs, except for the kidneys. However, the uptake mechanism of these derivatives remains unclear, and uptake via specific amino acid transporters needs to be demonstrated.
KW - Bifunctional chelating agent
KW - DO2A
KW - DO3A
KW - DOTA
KW - Gallium
UR - http://www.scopus.com/inward/record.url?scp=78049469914&partnerID=8YFLogxK
U2 - 10.1016/j.nucmedbio.2010.06.003
DO - 10.1016/j.nucmedbio.2010.06.003
M3 - Article
C2 - 21055619
AN - SCOPUS:78049469914
SN - 0969-8051
VL - 37
SP - 893
EP - 902
JO - Nuclear Medicine and Biology
JF - Nuclear Medicine and Biology
IS - 8
ER -